Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline and ceftriaxone as alternatives to penicillin G for early syphilis
ChiCTR-TQR-13003624Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ceftriaxone, doxycycline and benzathine penicillin G in syphilis (3 arms), sponsored by Institute of Dermatology, Chinese Academy of Medical Sciences. Primary endpoints: Rapid plasma reagin test, Signs and symptoms of syphilis and 4 more. Started Oct 2013; status: completed.
02
Drugs
ceftriaxonedoxycyclinebenzathine penicillin G
03
Conditions
syphilis
Beyond the preview
Go deeper on ChiCTR-TQR-13003624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TQR-13003624.